GlucoSet

GlucoSet aims to make glucose control in ICUs possible, to reduce mortality, complications and costs. Blood glucose levels are elevated and unstable in hospital intensive care unit (ICU) patients. This leads to costly infections, increased length of stay and mortality. The GlucoSet intravascular sensor delivers continuous and accurate information on patients blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels

Glucoset operates in the Medical equipment manufacturing industry.

Glucoset's revenue is 11m - 100m

Glucoset has 11 - 50 employees.